Trial Profile
A Three-Period, Three-Treatment, Six-Sequence Randomized Crossover Study of the Bioavailability and Pharmacokinetics of Diazepam After Intranasal and Intravenous Administration to Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Feb 2022
Price :
$35
*
At a glance
- Drugs Diazepam (Primary) ; Diazepam
- Indications Epilepsy
- Focus Pharmacokinetics
- 07 Feb 2012 Status changed from active, no longer recruiting to completed.
- 02 Dec 2011 Primary endpoint 'Drug-bioavailability' has been met.
- 02 Dec 2011 Results presented at the 65th Annual Meeting of the American Epilepsy Society.